SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601485-21-000048
Filing Date
2021-08-12
Accepted
2021-08-12 16:10:29
Documents
13
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K angn-20210812.htm   iXBRL 8-K 35294
2 EX-99.1 ex991_06302021-8k.htm EX-99.1 93496
  Complete submission text file 0001601485-21-000048.txt   279737

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20210812.xsd EX-101.SCH 1987
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20210812_lab.xml EX-101.LAB 25136
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20210812_pre.xml EX-101.PRE 13128
6 EXTRACTED XBRL INSTANCE DOCUMENT angn-20210812_htm.xml XML 11210
Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 211167624
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences